FindTrial
Sign In

HER2-targeted therapy

DRUG2 trials

Sponsors

SWOG Cancer Research Network, Memorial Sloan Kettering Cancer Center

Conditions

Anatomic Stage IV Breast Cancer AJCC v8Breast CancerHER2-positive Breast CancerMetastatic HER2-Positive Breast CarcinomaOligometastatic Breast Carcinoma

Phase 3

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
RecruitingNCT07578116
SWOG Cancer Research NetworkAnatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma, Oligometastatic Breast Carcinoma
Start: 2027-03-09End: 2033-05-31Target: 562Updated: 2026-10-13

Unknown Phase

A Study of Skipping Radiation Therapy in People With Breast Cancer
RecruitingNCT07895511
Memorial Sloan Kettering Cancer CenterHER2-positive Breast Cancer, Breast Cancer
Start: 2026-10-16End: 2031-10-16Target: 136Updated: 2026-10-29